An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration

• Ashley D. Olson ,

  * E-mail: a.olson@ucl.ac.uk

  Affiliation Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom

  ⨯
• Laurence Meyer,

  Affiliation Institut National de la Santé et de la Recherche Médicale U1018, Université Paris-Sud, le Kremlin-Bicêtre, France

  ⨯
• Maria Prins,

  Affiliation Amsterdam Public Health Service, Amsterdam, Netherlands

  ⨯
• Rodolphe Thiebaut,

  Affiliation Institut National de la Santé et de la Recherche Médicale U897, Université Bordeaux Segalen, Bordeaux, France

  ⨯
• Deepti Gurdasani,

  Affiliations Wellcome Trust Sanger Institute, Hinxton, United Kingdom, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Marguerite Guiguet,

  Affiliations Institut National de la Santé et de la Recherche Médicale U943, Paris, France, Université Pierre et Marie Curie S943, Paris, France

  ⨯
• Marie-Laure Chaix,

  Affiliation Université Paris Descartes, EA 3620, Hôpital Necker-Enfants Malades, Paris, France

  ⨯
• Pauli Amornkul,

  Affiliation International AIDS Vaccine Initiative, San Francisco, California, United States of America

  ⨯
• Abdel Babiker,

  Affiliation Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom

  ⨯
• Manjinder S. Sandhu,

  Affiliations Wellcome Trust Sanger Institute, Hinxton, United Kingdom, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Kholoud Porter,

  Affiliation Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom

  ⨯
• for C. A. S. C. A. D. E. Collaboration in EuroCoord

  ¶Membership of the CASCADE Collaboration in EuroCoord is provided in the Acknowledgments.

  ⨯